Predrug approval clinical trials are usually designed to assess clinical efficacy but not necessarily clinical safety. This paper reviews the problems in thoroughly evaluating clinical safety using only predrug approval clinical data and demonstrates these problems through examples.
KaitinKIMattisonNYNorthingtonFKLasagnaL. The drug lag: an update of new drug introductions in the United States and in the United Kingdom, 1977 through 1987. Clin Pharmacol Ther. 1989;46:121–138.
2.
UedaK. Adverse drug reactions in clinical trials. Clin Eval. 1987;15:417–422.
3.
Stedman's Medical Dictionary Illustrated. 23rd Edition. Baltimore, MD: Williams & Wilkins; 1976.
4.
Churchill's Medical Dictionary. New York: Churchill Livingstone; 1989.
